US Patent Issued to Miotox on July 22 for "Zonal and targeted methods and uses for treating a post-traumatic stress disorder" (California Inventor)

ALEXANDRIA, Va., July 23 -- United States Patent no. 12,364,740, issued on July 22, was assigned to Miotox LLC (Beverly Hills, Calif.).

"Zonal and targeted methods and uses for treating a post-traumatic stress disorder" was invented by William J. Binder (Beverly Hills, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present specification discloses methods for treating a PTSD. The methods comprise extramuscularly administering a Botulinum toxin to an individual in one or more areas of a fronto-fascial layer located in a frontal head region, one or more areas of a temporoparietal-fascial layer located in a temporal head region, and one or more areas of an occipito-fascial layer located in an occipita...